Modes and duration
- Full-time: 1 year
- Flexible: 2-5 years
Tuition Fees (2015/16)
- £11,125 (FT)
- £24,410 (FT)
- All applicants:
- 31 July 2015
Applicants should be: a qualified medical practitioner, with a qualification equivalent to a UK MB BS, a non-clinical scientist with a minimum of an upper second-class BSc or equivalent in a life or biomedical science subject; or a healthcare, pharmaceutical or biotech professional and scientist with equivalent experience (minimum 3 years).
The English language level for this programme is: Standard
Further information can be found on our English language requirements page.
Country-specific information, including details of when UCL representatives are visiting your part of the world, can be obtained from the International Students website.
International applicants can find out the equivalent qualification for their country by selecting from the list below.
Select your country:
The degree covers all aspects of the subject, including basic biomedical science, molecular basis of disease, current and developing technologies and clinical applications. Students also receive vocational training in research methodology and statistics, how to perform a research project and in completing a practical laboratory based project.
Students undertake modules to the value of 180 credits.
The MSc programme consists of four core modules (60 credits), four optional modules (60 credits) and a research dissertation (60 credits).
A Postgraduate Diploma (120 credits, full-time nine months or part-time up to five years) is offered
A Postgraduate Certificate (60 credits, full-time 12 weeks or up to two years part-time) is offered.
- Molecular Aspects of Cell and Gene Therapy
- Clinical Applications of Cell and Gene Therapy
- Research Methodology and Statistics
- Stem Cell and Tissue Repair
- Foundations of Biomedical Sciences
- Applied Genomics
- HIV Frontiers from Research to Clinics
- Molecular and Genetic Basis of Paediatric Disease
- Understanding Research and Critical Appraisal: Biomedicine
- Laboratory Methods in Biomedical Science
All MSc students undertake an independent research project which culminates in a dissertation.
Teaching and Learning
Teaching includes lectures, seminars, problem classes and tutorials. Course assessment varies depending on the course, but includes written coursework, multiple-choice questions, written examinations, a practical analysis exam and the dissertation.
More scholarships are listed on the scholarships website
The majority of our graduates have gone on to secure PhD places. Please see our MSc Cell and Gene Therapy programme website to read testimonials from past students which include their destinations following graduation.
Top career destinations for this degree
- PhD, UCL Institute of Child Health (2013)
- PhD, St George's University of London (2012)
- PhD, King's College London (2012)
- PhD, University of Nebraska Medical Centre (2012)
This novel course aims to equip students for careers in research, education, medicine and business in academic, clinical and industrial settings. Examples of potential careers could include academic research and/or lecturing in a university or other higher education setting, conducting clinical trials as part of a team of clinicians, scientists and allied health professionals, monitoring and analysing the results of clinical trials as part of a clinical trials unit, developing new therapies or intellectual property in the pharmaceutical industry or other business venture.
Why study this degree at UCL?
The Institute of Child Health (ICH), and its clinical partner Great Ormond Street Hospital (GOSH), is the largest centre in Europe devoted to clinical and basic research and post-graduate education in children's health. ICH/GOSH is a major centre for cell therapy, including haematopoietic stem cell transplantation (HSCT) and gene therapy.
We are one of the global leaders in clinical trials of gene therapy, and we are currently conducting three clinical trials of gene therapy for three separate disorders, with clinical trials for additional disorders, including some forms of cancer, in development.
There is a strong research interest in cell and gene therapy within the School of Life and Medical Sciences (SLMS) at UCL, which has the largest concentration of clinicians and researchers active in this area of translational medicine in Europe. This is reflected by many groups conducting high-quality research and clinical trials using gene or cell therapy, including researchers in the Institute of Child Health, Division of Infection and Immunity, Institute of Ophthalmology, Institute for Women's Health, Institute of Genetics and the Cancer Institute.
Student / staff ratios › 370 staff › 198 taught students › 165 research students
Department: Institute of Child Health
"I came across the field of gene therapy while I was studying my BSc in Biotechnology back home at Universitat Autònoma de Barcelona (UAB). After one year of part-time research experience on gene therapy for a rare metabolic disease, I felt I could develop my professional career in this field and decided to make it the main theme of my postgraduate education. This is the reason why I applied to UCL for my MSc studies. The UK is one of the leading countries in gene therapy, and UCL in particular is a world-ranked university that gathers a great number of the country’s leading academics in this technology. As a matter of fact, it is the only university in the UK providing a postgraduate education focusing specifically on cell and gene therapy. It is very exciting to know that by studying at UCL I got the chance to learn and interact with leading experts in the field."
Miguel Calero GarciaSubject: Cell and Gene Therapy MSc
"I first moved to UCL in 2000 to do a PhD in Fetal Medicine and I have stayed ever since. The most attractive thing about UCL for me was the history of research and innovation within fetal medicine. This included major breakthroughs in treating fetal disease in the womb, such as fetal blood transfusion and shunts that are now performed routinely around the world. My main research is in translational medicine. I lead the Prenatal Cell and Gene Therapy Group at the UCL Institute for Women's Health. Our aim is to develop prenatal therapies for life-threatening disorders, for example congenital diseases such as thalassaemia, or obstetric complications such as fetal growth restriction. The best thing about working at UCL is the breadth of expertise in related medical and life sciences disciplines. Staff are always ready to discuss an idea and collaborate outside their field. "
Dr Anna DavidSubject: Cell and Gene Therapy MSc, Surgical and Interventional Sciences MSc, British Heart Foundation Cardiovascular Biomedicine PhD
Application and next steps
Students are advised to apply as early as possible due to competition for places. Those applying for scholarship funding (particularly overseas applicants) should take note of application deadlines.
Who can apply?
The programme is designed for medics and scientists who would like to develop their knowledge in this distinct area, with a view to contributing to research and clinical trials in the field.
- All applicants
For more information see our Applications page.Apply now
What are we looking for?When we assess your application we would like to learn:
- why you want to study Cell and Gene Therapy at graduate level
- why you want to study Cell and Gene Therapy at UCL
- what particularly attracts you to this programme
- how your academic and professional background meets the demands of this challenging programme
- where you would like to go professionally with your degree